LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 15.25
-2.10 (-12.10%)
Sep 11, 2026, 1:58 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 501.43 million as of September 11, 2026. Its market cap has decreased by -41.14% in one year.
Market Cap
501.43M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
15.25
ChartMarket Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 501.43M, a decrease of -30.46%. That is a compound annual growth rate of -12.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 501.43M | -33.97% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 834.03M |
| Neith | 793.51M |
| Lukas Biomedical | 766.30M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 711.93M |
| Taiwan Advance Bio-Pharmaceutical | 644.40M |
| SynCore Biotechnology Co.,Ltd | 641.76M |
| TaiwanJ Pharmaceuticals | 551.24M |